Microneedle‐Based Local Delivery of CCL22 and IL‐2 Enriches Treg Homing to the Skin Allograft and Enables Temporal Monitoring of Immunotherapy Efficacy
- 24 May 2021
- journal article
- research article
- Published by Wiley in Advanced Functional Materials
- Vol. 31 (44) , 2100128
Abstract
Skin allografts only serve as temporary dressing for patients suffering major burns due to their high immunogenicity and rejection by the immune system, requiring systemic immunosuppressive therapies that lead to deleterious side effects. Microneedle arrays composed of hyaluronic acid (HA) and placed on skin allografts can locally deliver immunomodulators and simultaneously sample immune cells in interstitial fluid to monitor the response to the therapy. The cells can be retrieved from the microneedles for downstream analysis by degrading the HA using a reducing agent. Using an allogeneic skin transplantation model, it is shown that the microneedle‐mediated local delivery of the chemokine CCL22 (to attract Tregs) and the cytokine IL‐2 (to promote their expansion) increases the local immune suppression in the allograft. Moreover, immune cell population in the allograft correlates with that seen in the microneedles. The delivery and sampling functions of the microneedle arrays can help regulate the immune system locally, without inducing systemic immune suppression, and facilitate the monitoring of the response to the therapy following skin transplantation.Keywords
Funding Information
- National Institutes of Health (RO1 Al134842)
- American Heart Association (120236)
This publication has 49 references indexed in Scilit:
- Fundamental Immunology of Skin Transplantation and Key Strategies for Tolerance InductionArchivum Immunologiae et Therapiae Experimentalis, 2013
- Bioinspired Controlled Release of CCL22 Recruits Regulatory T Cells In VivoAdvanced Materials, 2012
- TH17, TH22 and TReg Cells Are Enriched in the Healthy Human CecumPLOS ONE, 2012
- Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic isletsJournal of Clinical Investigation, 2011
- IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cellsJournal of Experimental Medicine, 2010
- Mechanism of cellular rejection in transplantationPediatric Nephrology, 2010
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007
- Immune Responses in Transplantation: Application to Composite Tissue AllograftSeminars in Plastic Surgery, 2007
- Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory diseaseJournal of Experimental Medicine, 2007
- Burn Wound InfectionsClinical Microbiology Reviews, 2006